WEIGHT MANAGEMENT
GLP-1 Program
A physician-supervised weight-management program that evaluates whether a GLP-1 medication fits a patient’s health profile and goals.
What it is
A GLP-1 program combines medical assessment, prescription medication when appropriate, nutrition guidance, and ongoing follow-up. Medication selection is individualized and not assumed at the first visit.
How it works
GLP-1 receptor medicines affect pathways involved in appetite and fullness. The program tracks weight, symptoms, medication tolerance, and health markers while addressing food intake, movement, sleep, and relevant conditions. A clinician may change or discontinue therapy when the risk-benefit assessment changes.
Who it is for
- Adults seeking a structured medical approach to weight management
- Patients with weight-related health risks needing clinician oversight
- Patients who value regular accountability and medication education
Mechanism in depth
The GLP-1 Program wraps GLP-1 or dual-agonist medication in a broader clinical framework: baseline labs, nutrition guidance, resistance training coaching to preserve lean mass, side effect management, and monthly medical review. The medication is one lever; the program is the system that supports adherence and safety.
What outcomes to expect
Program participants generally see similar weight loss to medication alone, with meaningfully better preservation of muscle mass and better long-term maintenance. Improvements in energy, sleep, and metabolic markers often accompany the weight change.
Individual response varies. GPLX does not guarantee results. Your physician sets expectations based on your health history and lab findings.
Common side effects
The medication side effects are the same as for semaglutide or tirzepatide alone. The program design addresses common ramp-up issues proactively through nutrition and hydration coaching.
Monitoring schedule
Baseline labs and body composition, then monthly check-ins during the first three months, then every three months. Body composition is remeasured periodically to track lean mass preservation.
Not appropriate if
Same medication contraindications as semaglutide and tirzepatide. Program participation also requires willingness to engage with the nutrition and training components.
Biomarkers reviewed with this treatment
Your physician reviews these markers before and during therapy. Click any marker for a plain-English explanation of what it measures and why it matters.
This treatment is only available after a physician consultation. Book your $149 intake to see if it is appropriate for you.
Book a $149 Consultation